Monday, 16 November 2015

Full text of “Chinese Drug Recall Regulations 2015" Research Report Review

China is one of the fastest growing global economies with a fifth population in the world, and is one of the largest healthcare markets around the world. Along with sustained economic and population growth, Chinese healthcare market has maintained annually average growth rate above 16 % since 1990s. By 2013, total value of drugs on Chinese healthcare market has reached RMB 1114 billion. On the Chinese healthcare market, imported drugs made by overseas and multinational pharmaceutical manufacturers account for about one fourth. It is estimated that total value of drugs on Chinese healthcare market will be likely to be more than RMB 1450 billion by 2015, and will surpass Japan to become the second largest drug market following the United States. The Chinese healthcare market will attract more and more overseas pharmaceutical manufacturers and producers to penetrate such market. 

Latest guidebook for Chinese Drug Recall Regulations (2014 Edition) is an essential resource for overseas and multinational pharmaceutical manufacturers and producers to handle a drug recall smoothly in China, which provides a detailed guidance of comprehensive and thorough knowledge of the Chinese drug recall regulations. 
Table Of Content 

Chapter 1 Introduction.2

Chapter 2  An Overview of Chinese Regulatory Authorities for Drug Recall.4

Request A Sample copy of This Report @

Chapter 3 General Regulations for Drug Recall.6
3.1. Definitions.6
3.2. The special regulations for overseas manufacturers of imported drugs.6
3.3. Who, Where and How to Submit the Report relating to Drug Recall?.6
3.4. The Manufacturers Duty for Drug Recall.7
3.5. The Distributor and User Facilitys Duty for Drug Recall.8

Chapter 4 Voluntary Recall of Drugs.11
4.1. Regulations for Voluntary Recall of Drugs.11
4.2. An Entire Process of Voluntary Recall of Drugs.13

Chapter 5 Mandatory Recall of Drugs.16
5.1. Regulations for Mandatory Recall of Drugs.16
5.2. Entire Process of Mandatory Recall of Drugs.18

Chapter 6 Legal Liabilities.22

Chapter 7 Case Study
Agent (Xi'an-Janssen Pharmaceutical Ltd) Recall Imported Drug Caelyx and Velcade produced at Ben Venue Laboratories, U.S.A. 25

About Us:
Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Information:

Ryan Shaw

Felton Office Plaza,
6265 Highway 9,
Felton, California, 95018,
United States
Phone Number

No comments:

Post a Comment